In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Scientists have created a new 'biocooperative' material based on blood, which has shown to successfully repair bones, paving the way for personalised regenerative blood products that could be used as ...

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size.

Scientists have developed a groundbreaking ‘biocooperative’ material using blood that not only repairs bones but also enhances natural healing processes. This new material, created by combining ...